Olympic controversies and GLP-1 for Alzheimer's and Heart Failure
Aug 7 2024
Length: 27 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

Listen for free

View show details

Summary
Drs. Karl and Spencer talk about the top line results from study showing liraglutide may have some benefit in Alzheimer's along with top line results from the Summit trial showing heart failure benefits with tirzepatide.
They also discuss the women's boxing controversy and BMI in athletes.

Show More Show Less

Physical Illness & Disease Hygiene & Healthy Living

Show More Show Less

What listeners say about Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon